 Chandra Tucker
Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Optogenetics | 10 | 2024 | 95 | 4.320 |
Why?
| | Cryptochromes | 11 | 2020 | 23 | 4.120 |
Why?
| | Light | 17 | 2020 | 336 | 3.750 |
Why?
| | Arabidopsis Proteins | 10 | 2019 | 65 | 3.210 |
Why?
| | Proteins | 8 | 2021 | 906 | 2.370 |
Why?
| | Protein Multimerization | 5 | 2021 | 157 | 2.290 |
Why?
| | Integrases | 4 | 2019 | 116 | 1.390 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 6 | 2019 | 225 | 1.310 |
Why?
| | Arabidopsis | 6 | 2017 | 79 | 1.170 |
Why?
| | Protein Engineering | 3 | 2017 | 98 | 1.130 |
Why?
| | Dimerization | 4 | 2021 | 176 | 1.110 |
Why?
| | High-Throughput Screening Assays | 2 | 2021 | 123 | 1.030 |
Why?
| | Alleles | 4 | 2014 | 789 | 1.010 |
Why?
| | HEK293 Cells | 8 | 2021 | 590 | 0.940 |
Why?
| | Huntington Disease | 1 | 2024 | 40 | 0.870 |
Why?
| | Transaminases | 3 | 2014 | 24 | 0.870 |
Why?
| | Saccharomyces cerevisiae | 6 | 2012 | 476 | 0.840 |
Why?
| | Endopeptidases | 1 | 2022 | 70 | 0.810 |
Why?
| | Mammals | 2 | 2022 | 241 | 0.800 |
Why?
| | Two-Hybrid System Techniques | 5 | 2015 | 52 | 0.770 |
Why?
| | Green Fluorescent Proteins | 2 | 2021 | 370 | 0.770 |
Why?
| | Hyperoxaluria, Primary | 2 | 2014 | 14 | 0.760 |
Why?
| | Gene Expression Regulation | 3 | 2019 | 2322 | 0.720 |
Why?
| | Calcium-Binding Proteins | 2 | 2020 | 205 | 0.660 |
Why?
| | Protein Interaction Mapping | 3 | 2014 | 101 | 0.640 |
Why?
| | Transcription, Genetic | 3 | 2014 | 1310 | 0.640 |
Why?
| | Genetic Engineering | 1 | 2019 | 80 | 0.630 |
Why?
| | Genes, Reporter | 3 | 2019 | 256 | 0.630 |
Why?
| | Transcription Factors | 5 | 2020 | 1526 | 0.630 |
Why?
| | Recombination, Genetic | 1 | 2019 | 176 | 0.620 |
Why?
| | Enzyme Stability | 3 | 2014 | 62 | 0.600 |
Why?
| | Peroxisomes | 2 | 2015 | 9 | 0.540 |
Why?
| | Mutation | 4 | 2014 | 3338 | 0.530 |
Why?
| | COS Cells | 4 | 2021 | 175 | 0.530 |
Why?
| | Photoreceptor Cells | 2 | 2012 | 12 | 0.520 |
Why?
| | Phototropins | 1 | 2015 | 2 | 0.510 |
Why?
| | Avena | 1 | 2015 | 4 | 0.510 |
Why?
| | Transcriptional Activation | 1 | 2017 | 337 | 0.510 |
Why?
| | Phytochrome B | 2 | 2012 | 3 | 0.510 |
Why?
| | Molecular Imaging | 2 | 2015 | 50 | 0.500 |
Why?
| | Protein Transport | 2 | 2018 | 391 | 0.490 |
Why?
| | Phytochrome | 1 | 2014 | 2 | 0.480 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2014 | 100 | 0.450 |
Why?
| | Protein Folding | 2 | 2012 | 239 | 0.440 |
Why?
| | Recombinant Proteins | 2 | 2019 | 1228 | 0.430 |
Why?
| | Cluster Analysis | 1 | 2014 | 452 | 0.420 |
Why?
| | Protein Binding | 5 | 2019 | 1888 | 0.400 |
Why?
| | Gene Expression Regulation, Fungal | 1 | 2012 | 59 | 0.400 |
Why?
| | Animals | 16 | 2022 | 31565 | 0.380 |
Why?
| | Models, Molecular | 4 | 2017 | 1368 | 0.350 |
Why?
| | Yeasts | 3 | 2014 | 49 | 0.340 |
Why?
| | Evaluation Studies as Topic | 1 | 2009 | 167 | 0.320 |
Why?
| | Cytoskeletal Proteins | 1 | 2009 | 145 | 0.310 |
Why?
| | Drug Evaluation, Preclinical | 2 | 2012 | 159 | 0.290 |
Why?
| | Protein Domains | 3 | 2018 | 207 | 0.270 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2009 | 367 | 0.270 |
Why?
| | DNA-Binding Proteins | 4 | 2017 | 1311 | 0.260 |
Why?
| | Genetic Predisposition to Disease | 1 | 2014 | 2090 | 0.260 |
Why?
| | Humans | 19 | 2024 | 114045 | 0.260 |
Why?
| | Polymorphism, Genetic | 1 | 2008 | 610 | 0.250 |
Why?
| | Neurons | 2 | 2015 | 1277 | 0.240 |
Why?
| | Nuclear Proteins | 1 | 2009 | 591 | 0.240 |
Why?
| | Receptors, Peptide | 1 | 2004 | 15 | 0.230 |
Why?
| | Protein Structure, Tertiary | 3 | 2014 | 796 | 0.230 |
Why?
| | Guanylate Cyclase | 1 | 2004 | 32 | 0.230 |
Why?
| | Point Mutation | 2 | 2004 | 216 | 0.230 |
Why?
| | Retinal Degeneration | 1 | 2004 | 30 | 0.230 |
Why?
| | Genes, Recessive | 1 | 2004 | 74 | 0.220 |
Why?
| | Blindness | 1 | 2004 | 36 | 0.220 |
Why?
| | Genes, Lethal | 1 | 2003 | 26 | 0.220 |
Why?
| | Proteostasis | 1 | 2024 | 20 | 0.220 |
Why?
| | Plant Proteins | 2 | 2015 | 81 | 0.220 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2015 | 192 | 0.220 |
Why?
| | Serogroup | 1 | 2022 | 27 | 0.210 |
Why?
| | Proteolysis | 1 | 2022 | 142 | 0.200 |
Why?
| | Gene Expression Regulation, Plant | 2 | 2012 | 47 | 0.190 |
Why?
| | Substrate Specificity | 1 | 2022 | 350 | 0.190 |
Why?
| | Microscopy, Fluorescence | 2 | 2021 | 393 | 0.190 |
Why?
| | RNA-Binding Protein FUS | 1 | 2021 | 11 | 0.180 |
Why?
| | Kinetics | 2 | 2016 | 1547 | 0.170 |
Why?
| | Cell Compartmentation | 1 | 2019 | 51 | 0.170 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2021 | 167 | 0.160 |
Why?
| | Recombinant Fusion Proteins | 2 | 2012 | 613 | 0.160 |
Why?
| | Protein Structure, Quaternary | 1 | 2019 | 115 | 0.160 |
Why?
| | Luciferases | 1 | 2019 | 142 | 0.160 |
Why?
| | Fluorescent Dyes | 1 | 2020 | 298 | 0.150 |
Why?
| | Botulinum Toxins | 1 | 2019 | 39 | 0.150 |
Why?
| | Holoenzymes | 1 | 2018 | 21 | 0.150 |
Why?
| | Luminescent Proteins | 1 | 2019 | 166 | 0.150 |
Why?
| | Signal Transduction | 4 | 2016 | 4501 | 0.150 |
Why?
| | Saccharomyces cerevisiae Proteins | 2 | 2012 | 333 | 0.150 |
Why?
| | Synaptic Transmission | 1 | 2019 | 227 | 0.140 |
Why?
| | Animals, Genetically Modified | 1 | 2017 | 215 | 0.140 |
Why?
| | Cell Line | 2 | 2017 | 2629 | 0.140 |
Why?
| | Photochemical Processes | 1 | 2017 | 98 | 0.130 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2018 | 156 | 0.130 |
Why?
| | Amino Acid Sequence | 3 | 2016 | 1981 | 0.130 |
Why?
| | Zebrafish | 2 | 2017 | 413 | 0.120 |
Why?
| | Software | 1 | 2019 | 526 | 0.120 |
Why?
| | Actin-Related Protein 2 | 1 | 2014 | 3 | 0.120 |
Why?
| | Peroxisomal Disorders | 1 | 2014 | 2 | 0.120 |
Why?
| | Clathrin | 1 | 2014 | 24 | 0.120 |
Why?
| | Gene Expression | 1 | 2019 | 1417 | 0.120 |
Why?
| | Cytosol | 1 | 2014 | 201 | 0.110 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 157 | 0.110 |
Why?
| | Mutant Proteins | 1 | 2014 | 95 | 0.110 |
Why?
| | Endocytosis | 1 | 2014 | 146 | 0.110 |
Why?
| | Embryo, Mammalian | 1 | 2014 | 213 | 0.110 |
Why?
| | Peripheral Nervous System Diseases | 1 | 2014 | 120 | 0.110 |
Why?
| | Cytoskeleton | 1 | 2014 | 176 | 0.110 |
Why?
| | HeLa Cells | 1 | 2014 | 563 | 0.100 |
Why?
| | Phycobilins | 1 | 2012 | 1 | 0.100 |
Why?
| | Phycocyanin | 1 | 2012 | 2 | 0.100 |
Why?
| | Galactokinase | 1 | 2012 | 4 | 0.100 |
Why?
| | beta-Galactosidase | 1 | 2012 | 62 | 0.100 |
Why?
| | Actins | 1 | 2014 | 376 | 0.100 |
Why?
| | Peptide Elongation Factor Tu | 1 | 2012 | 5 | 0.100 |
Why?
| | Light Signal Transduction | 1 | 2012 | 4 | 0.100 |
Why?
| | Opsins | 1 | 2012 | 10 | 0.100 |
Why?
| | Cell Nucleus | 1 | 2014 | 552 | 0.100 |
Why?
| | Heat-Shock Proteins | 1 | 2012 | 112 | 0.090 |
Why?
| | Promoter Regions, Genetic | 2 | 2012 | 1131 | 0.090 |
Why?
| | Photic Stimulation | 1 | 2012 | 203 | 0.090 |
Why?
| | Mice | 4 | 2019 | 14843 | 0.090 |
Why?
| | Genetic Association Studies | 1 | 2012 | 339 | 0.090 |
Why?
| | Complex Mixtures | 1 | 2010 | 11 | 0.090 |
Why?
| | Ligands | 2 | 2009 | 556 | 0.090 |
Why?
| | Protein Conformation | 1 | 2012 | 803 | 0.080 |
Why?
| | Methods | 1 | 2009 | 57 | 0.080 |
Why?
| | Ultraviolet Rays | 1 | 2012 | 363 | 0.080 |
Why?
| | Brain | 2 | 2018 | 2355 | 0.080 |
Why?
| | Hydrogen | 1 | 2009 | 59 | 0.080 |
Why?
| | Genetic Techniques | 1 | 2009 | 57 | 0.080 |
Why?
| | Deuterium | 1 | 2009 | 79 | 0.080 |
Why?
| | Oxamic Acid | 1 | 2008 | 1 | 0.080 |
Why?
| | Genetic Complementation Test | 1 | 2008 | 62 | 0.080 |
Why?
| | Peptide Hydrolases | 1 | 2009 | 103 | 0.080 |
Why?
| | Pyridoxal Phosphate | 1 | 2008 | 19 | 0.080 |
Why?
| | Vitamin B Complex | 1 | 2008 | 38 | 0.080 |
Why?
| | Pharmaceutical Preparations | 1 | 2010 | 164 | 0.070 |
Why?
| | Sensitivity and Specificity | 1 | 2012 | 1690 | 0.070 |
Why?
| | Peptide Fragments | 1 | 2012 | 665 | 0.070 |
Why?
| | Cyclic GMP | 2 | 2004 | 78 | 0.070 |
Why?
| | Immunity, Innate | 1 | 2012 | 720 | 0.070 |
Why?
| | Reproducibility of Results | 1 | 2012 | 2764 | 0.060 |
Why?
| | Disease Models, Animal | 1 | 2014 | 3498 | 0.060 |
Why?
| | Models, Biological | 1 | 2012 | 1611 | 0.060 |
Why?
| | Cells, Cultured | 3 | 2019 | 3861 | 0.060 |
Why?
| | Proteomics | 1 | 2010 | 815 | 0.060 |
Why?
| | Receptors, Guanylate Cyclase-Coupled | 1 | 2004 | 1 | 0.060 |
Why?
| | Receptors, Enterotoxin | 1 | 2004 | 4 | 0.060 |
Why?
| | Guanylate Cyclase-Activating Proteins | 1 | 2004 | 4 | 0.060 |
Why?
| | Genes, Dominant | 1 | 2004 | 93 | 0.060 |
Why?
| | Catalytic Domain | 1 | 2004 | 196 | 0.050 |
Why?
| | Transducin | 1 | 2003 | 40 | 0.050 |
Why?
| | Retinal Cone Photoreceptor Cells | 1 | 2003 | 14 | 0.050 |
Why?
| | Pharmacology | 1 | 2002 | 7 | 0.050 |
Why?
| | Nucleic Acid Hybridization | 1 | 2002 | 187 | 0.050 |
Why?
| | Cytoplasm | 1 | 2003 | 255 | 0.050 |
Why?
| | Biological Assay | 1 | 2002 | 112 | 0.050 |
Why?
| | Transfection | 1 | 2004 | 863 | 0.050 |
Why?
| | Blotting, Western | 1 | 2004 | 1143 | 0.050 |
Why?
| | Rats | 2 | 2019 | 4913 | 0.040 |
Why?
| | Vesicle-Associated Membrane Protein 2 | 1 | 2019 | 15 | 0.040 |
Why?
| | SNARE Proteins | 1 | 2019 | 37 | 0.040 |
Why?
| | Thermodynamics | 2 | 2010 | 380 | 0.040 |
Why?
| | Mice, Inbred C57BL | 2 | 2019 | 4680 | 0.040 |
Why?
| | Kidney | 1 | 2004 | 1182 | 0.040 |
Why?
| | Exons | 1 | 2018 | 301 | 0.030 |
Why?
| | Calcium | 1 | 2003 | 1089 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2018 | 337 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2018 | 270 | 0.030 |
Why?
| | Mass Spectrometry | 2 | 2010 | 622 | 0.030 |
Why?
| | Synapses | 1 | 2019 | 331 | 0.030 |
Why?
| | Gene Order | 1 | 2015 | 24 | 0.030 |
Why?
| | Caenorhabditis elegans | 1 | 2019 | 268 | 0.030 |
Why?
| | Fiber Optic Technology | 1 | 2015 | 18 | 0.030 |
Why?
| | Photons | 1 | 2015 | 57 | 0.030 |
Why?
| | RNA, Messenger | 2 | 2018 | 2550 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 2014 | 2783 | 0.030 |
Why?
| | Peroxins | 1 | 2014 | 2 | 0.030 |
Why?
| | Motor Endplate | 1 | 2014 | 14 | 0.030 |
Why?
| | Mice, 129 Strain | 1 | 2014 | 77 | 0.030 |
Why?
| | Spinal Cord Diseases | 1 | 2014 | 38 | 0.030 |
Why?
| | Sciatic Nerve | 1 | 2014 | 56 | 0.030 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2014 | 134 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 1 | 2019 | 2182 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2014 | 353 | 0.030 |
Why?
| | Microscopy, Confocal | 1 | 2014 | 304 | 0.030 |
Why?
| | Heat Shock Transcription Factors | 1 | 2012 | 17 | 0.020 |
Why?
| | Salicylic Acid | 1 | 2012 | 8 | 0.020 |
Why?
| | Action Potentials | 1 | 2014 | 406 | 0.020 |
Why?
| | Open Reading Frames | 1 | 2012 | 117 | 0.020 |
Why?
| | Hippocampus | 1 | 2015 | 690 | 0.020 |
Why?
| | UDPglucose 4-Epimerase | 1 | 2010 | 2 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2014 | 1624 | 0.020 |
Why?
| | Motor Activity | 1 | 2014 | 635 | 0.020 |
Why?
| | Cyclosporine | 1 | 2010 | 161 | 0.020 |
Why?
| | Chromatography, Liquid | 1 | 2010 | 345 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2014 | 2562 | 0.020 |
Why?
| | Pregnancy | 1 | 2018 | 5499 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2014 | 1468 | 0.020 |
Why?
| | Adaptation, Ocular | 1 | 2003 | 4 | 0.010 |
Why?
| | Physical Chromosome Mapping | 1 | 2003 | 16 | 0.010 |
Why?
| | Vision, Ocular | 1 | 2003 | 30 | 0.010 |
Why?
| | Homozygote | 1 | 2003 | 187 | 0.010 |
Why?
| | Female | 2 | 2019 | 59324 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 2003 | 292 | 0.010 |
Why?
| | GTP-Binding Proteins | 1 | 2003 | 139 | 0.010 |
Why?
| | Mutagenesis | 1 | 2003 | 168 | 0.010 |
Why?
| | Organ Specificity | 1 | 2003 | 266 | 0.010 |
Why?
| | Larva | 1 | 2003 | 191 | 0.010 |
Why?
| | Male | 2 | 2019 | 55396 | 0.010 |
Why?
|
|
Tucker's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|